Aspira Womens Health Inc
For the period ended Jun 30, 2024. Filed Aug 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 13, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
The following exhibits are filed or incorporated by reference with this report as indicated below:
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit · Filing · Filed | ||||||
| Number | Exhibit Description | Form | File No. | Exhibit | Date | Herewith |
| 1.1 | At The Market Agreement between Aspira Women’s Health Inc. and H. C. Wainwright & Co., LLC dated August 2, 2024 | 8-K | 000-31617 | 1.1 | August 2, 2024 | |
| 4.1 | Form of Common Warrant | 8-K | 001-34810 | 4.1 | July 2, 2024 | |
| 4.2 | Form of Warrant | 8-K | 001-34810 | 4.1 | July 31, 2024 | |
| 10.1 | Form of Securities Purchase Agreement | 8-K | 001-34810 | 10.1 | July 2, 2024 | |
| 10.2 | Form of Warrant Inducement Agreement | 8-K | 001-34810 | 10.1 | July 31, 2024 | |
| 10.3 | Second Amended Employment Agreement between Aspira Women's Health Inc. and Nicole Sandford, effective September 1, 2024 | √ | ||||
| 10.4 | Amended Employment Agreement between Aspira Women's Health Inc. and Sandra Milligan, M.D., J.D., effective September 1, 2024 | √ | ||||
| 10.5 | Consulting Agreement between Aspira Women's Health Inc., by and between John Kallassy and Aspira Women's Health Inc. | √ | ||||
| 31.1 | Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | √ | ||||
| 31.2 | Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | √ | ||||
| 32.1** | Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | √√ | ||||
| 101.INS | Inline XBRL Instance Document - (the instant document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). | √ | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents | √ | ||||
| 104 | Cover page formatted as Inline XBRL and contained in Exhibit 101 | √ | ||||
√Filed herewith
√√Furnished herewith
**The certification attached as Exhibit 32.1 that accompany this Quarterly Report on Form 10-Q, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Form 10-Q), irrespective of any general incorporation language contained in such filing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.